Filing Flows

Filing Flows › Kenvue (KVUE) › Q3 2026 › vs Q2 2026

Kenvue (KVUE) Q3 2026 vs Q2 2026 (quarter over quarter)

Kenvue's revenue fell $69.0M (-2%) from $4.0B in Q2 2026 to $3.9B in Q3 2026. The biggest changes: Skin Health and Beauty −$74.0M (-7%); Self Care +$67.0M (+4%); Essential Health −$62.0M (-5%). Gross margin 59.5% against 58.2% (+1.4 pts).

Kenvue, Q3 2026: revenue $3.9B (+3% year over year), operating margin 18.2%, net earnings $430M, operating cash flow $700M. The chart draws each line against Q2 2026, the increases inside each band.

Kenvue: what changed, Q3 2026 vs Q2 2026Kenvue: what changed, Q3 2026 vs Q2 2026Cost of revenue−$82.0MSkin Health and Beauty−$74.0MSelf Care$67.0MEssential Health−$62.0MWorking capital & other$43.0MIncome tax$37.0MNet earnings−$26.0MCapital expenditures$16.0MGross profit$13.0MOperating cash flow$12.0M

Margins

Q3 2026Q2 2026Change
Gross margin59.5%58.2%+1.4 pts
Operating margin18.2%17.7%+0.5 pts
Net margin11.1%11.5%-0.5 pts
Free cash flow margin16.0%15.8%+0.2 pts

Every line

LineQ3 2026Q2 2026Change%
Self Care$1.7B$1.6B$67.0M+4%
Essential Health$1.2B$1.3B−$62.0M-5%
Skin Health and Beauty$1.0B$1.1B−$74.0M-7%
Revenue$3.9B$4.0B−$69.0M-2%
Gross profit$2.3B$2.3B$13.0M+0.6%
Cost of revenue$1.6B$1.7B−$82.0M-5%
Operating profit$706M$699M$7.0M+1%
Operating expenses$1.6B$1.6B$6.0M+0.4%
Pre-tax earnings$609M$598M$11.0M+2%
Other expense, net$97.0M$101M−$4.0M-4%
Net earnings$430M$456M−$26.0M-6%
Income tax$179M$142M$37.0M+26%
Depreciation & amortization$143M$145M−$2.0M-1%
Share-based compensation$29.0M$32.0M−$3.0M-9%
Working capital & other$98.0M$55.0M$43.0M+78%
Operating cash flow$700M$688M$12.0M+2%
Free cash flow (OCF − capex)$620M$624M−$4.0M-0.6%
Capital expenditures$80.0M$64.0M$16.0M+25%

Questions

How much did Kenvue's revenue grow quarter over quarter in Q3 2026?

Kenvue's revenue fell $69.0M (-2%) from $4.0B in Q2 2026 to $3.9B in Q3 2026.

What drove Kenvue's revenue change in Q3 2026?

Skin Health and Beauty −$74.0M (-7%); Self Care +$67.0M (+4%); Essential Health −$62.0M (-5%).

Q3 2026 results → · Compare in the interactive Sankey →